tradingkey.logo
tradingkey.logo
Suchen

Nanovibronix Inc

NAOV
Zur Watchlist hinzufügen
4.020USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
3.17MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Nanovibronix Inc Unternehmen

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Nanovibronix Inc Informationen

BörsenkürzelNAOV
Name des UnternehmensNanovibronix Inc
IPO-datumApr 24, 2015
CEOBesser (Doron)
Anzahl der mitarbeiter15
WertpapierartOrdinary Share
GeschäftsjahresendeApr 24
Addresse969 Pruitt Piace
StadtTYLER
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl75703
Telefon19142333004
Websitehttps://nanovibronix.com/
BörsenkürzelNAOV
IPO-datumApr 24, 2015
CEOBesser (Doron)

Führungskräfte von Nanovibronix Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
--
-100.00%
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Nanovibronix Inc?

Die fünf größten Anteilseigner von Nanovibronix Inc sind: Dr. Harold Jacob, M.D.

Wie viele Institutionen halten Anteile an Nanovibronix Inc (NAOV)?

Mit Stand vom 2026Q1 halten 17 Institutionen Anteile an Nanovibronix Inc, mit einem Gesamtmarktwert von etwa 44.60K, was 1.21% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 33009.00 gestiegen.